Cargando…

Streptococcus salivarius inhibits immune activation by periodontal disease pathogens

BACKGROUND: Periodontal disease represents a major health concern. The administration of beneficial microbes has been increasing in popularity over efforts to manipulate the microbes using antimicrobial agents. This study determined the ability of Streptococcus salivarius to inhibit IL-6 and IL-8 pr...

Descripción completa

Detalles Bibliográficos
Autores principales: MacDonald, Kyle W., Chanyi, Ryan M., Macklaim, Jean M., Cadieux, Peter A., Reid, Gregor, Burton, Jeremy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103598/
https://www.ncbi.nlm.nih.gov/pubmed/33962608
http://dx.doi.org/10.1186/s12903-021-01606-z
_version_ 1783689338267107328
author MacDonald, Kyle W.
Chanyi, Ryan M.
Macklaim, Jean M.
Cadieux, Peter A.
Reid, Gregor
Burton, Jeremy P.
author_facet MacDonald, Kyle W.
Chanyi, Ryan M.
Macklaim, Jean M.
Cadieux, Peter A.
Reid, Gregor
Burton, Jeremy P.
author_sort MacDonald, Kyle W.
collection PubMed
description BACKGROUND: Periodontal disease represents a major health concern. The administration of beneficial microbes has been increasing in popularity over efforts to manipulate the microbes using antimicrobial agents. This study determined the ability of Streptococcus salivarius to inhibit IL-6 and IL-8 production by gingival fibroblasts when activated by periodontal pathogens and their effect on the salivary microbiome. METHODS: Primary human gingival fibroblasts were challenged with Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans and Fusobacterium nucleatum and a combination of all three. IL-6 and IL-8 cytokine release were measured. Using this same model, S. salivarius K12, M18 and different supernatant and whole-cell lysate fractions of S. salivarius K12 were administered to pathogen-induced fibroblasts. A patient study of healthy participants was also conducted to determine the effect S. salivarius K12 had on the native microbiome using 16S next generation sequence analysis. RESULTS: All pathogens tested induced a significant IL-6 and IL-8 response. S. salivarius K12 or M18, did not exhibit an increase in inflammatory cytokines. When either of the probiotic strains were co-administered with a pathogen, there were significant reductions in both IL-6 and IL-8 release. This effect was also observed when gingival fibroblasts were pre-treated with either S. salivarius K12 or M18 and then stimulated with the oral pathogens. Chewing gum containing S. salivarius K12 did not alter the salivary microbiome and did not increase inflammatory markers in the oral cavity. CONCLUSION: S. salivarius K12 and M18 prevented immune activation induced by periodontal disease pathogens. S. salivarius K12 did not alter the salivary microbiome or induce immune activation when administered as a chewing gum. These results warrant further study to determine if it may be an effective treatment in a model of periodontal disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12903-021-01606-z.
format Online
Article
Text
id pubmed-8103598
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81035982021-05-10 Streptococcus salivarius inhibits immune activation by periodontal disease pathogens MacDonald, Kyle W. Chanyi, Ryan M. Macklaim, Jean M. Cadieux, Peter A. Reid, Gregor Burton, Jeremy P. BMC Oral Health Research Article BACKGROUND: Periodontal disease represents a major health concern. The administration of beneficial microbes has been increasing in popularity over efforts to manipulate the microbes using antimicrobial agents. This study determined the ability of Streptococcus salivarius to inhibit IL-6 and IL-8 production by gingival fibroblasts when activated by periodontal pathogens and their effect on the salivary microbiome. METHODS: Primary human gingival fibroblasts were challenged with Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans and Fusobacterium nucleatum and a combination of all three. IL-6 and IL-8 cytokine release were measured. Using this same model, S. salivarius K12, M18 and different supernatant and whole-cell lysate fractions of S. salivarius K12 were administered to pathogen-induced fibroblasts. A patient study of healthy participants was also conducted to determine the effect S. salivarius K12 had on the native microbiome using 16S next generation sequence analysis. RESULTS: All pathogens tested induced a significant IL-6 and IL-8 response. S. salivarius K12 or M18, did not exhibit an increase in inflammatory cytokines. When either of the probiotic strains were co-administered with a pathogen, there were significant reductions in both IL-6 and IL-8 release. This effect was also observed when gingival fibroblasts were pre-treated with either S. salivarius K12 or M18 and then stimulated with the oral pathogens. Chewing gum containing S. salivarius K12 did not alter the salivary microbiome and did not increase inflammatory markers in the oral cavity. CONCLUSION: S. salivarius K12 and M18 prevented immune activation induced by periodontal disease pathogens. S. salivarius K12 did not alter the salivary microbiome or induce immune activation when administered as a chewing gum. These results warrant further study to determine if it may be an effective treatment in a model of periodontal disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12903-021-01606-z. BioMed Central 2021-05-07 /pmc/articles/PMC8103598/ /pubmed/33962608 http://dx.doi.org/10.1186/s12903-021-01606-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
MacDonald, Kyle W.
Chanyi, Ryan M.
Macklaim, Jean M.
Cadieux, Peter A.
Reid, Gregor
Burton, Jeremy P.
Streptococcus salivarius inhibits immune activation by periodontal disease pathogens
title Streptococcus salivarius inhibits immune activation by periodontal disease pathogens
title_full Streptococcus salivarius inhibits immune activation by periodontal disease pathogens
title_fullStr Streptococcus salivarius inhibits immune activation by periodontal disease pathogens
title_full_unstemmed Streptococcus salivarius inhibits immune activation by periodontal disease pathogens
title_short Streptococcus salivarius inhibits immune activation by periodontal disease pathogens
title_sort streptococcus salivarius inhibits immune activation by periodontal disease pathogens
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103598/
https://www.ncbi.nlm.nih.gov/pubmed/33962608
http://dx.doi.org/10.1186/s12903-021-01606-z
work_keys_str_mv AT macdonaldkylew streptococcussalivariusinhibitsimmuneactivationbyperiodontaldiseasepathogens
AT chanyiryanm streptococcussalivariusinhibitsimmuneactivationbyperiodontaldiseasepathogens
AT macklaimjeanm streptococcussalivariusinhibitsimmuneactivationbyperiodontaldiseasepathogens
AT cadieuxpetera streptococcussalivariusinhibitsimmuneactivationbyperiodontaldiseasepathogens
AT reidgregor streptococcussalivariusinhibitsimmuneactivationbyperiodontaldiseasepathogens
AT burtonjeremyp streptococcussalivariusinhibitsimmuneactivationbyperiodontaldiseasepathogens